Peak Health Organization Emergency Drill for Sudden Accidents
Release time:
2020-08-14
Peak Health Organization Emergency Exercise
"All staff please note that there is a fire in the microwave drying room on the second floor of the Chinese herbal medicine workshop. All staff should gather at the road outside the workshop of the company's emergency assembly point, and all emergency teams should do a good job in emergency rescue." On the morning of 6# June 14 8 53 , the general manager of spike health technology company made such a voice in wechat group.
After hearing the message, all employees in the three workshops of extraction, Chinese herbal medicine and health food who were working were evacuated to safe positions in an orderly manner. At the same time of evacuation, the fire fighting and rescue team, environmental protection team, engineering rescue team, logistics support team, medical rescue team, and information release liaison team immediately started rescue work in accordance with their duties. The fire fighting and rescue team quickly put on the fire fighting clothing and autonomous breathing apparatus, and took the fire extinguisher to the scene to put out the fire. The environmental protection team closes and opens the rain gate valve, and contacts the environmental monitoring unit as appropriate for emergency monitoring. The engineering rescue team cut off the main power supply of the Chinese herbal medicine workshop and the power switch of the fire pump from manual to automatic. The logistics support team transferred irrelevant personnel on site and delimited the warning range; the medical rescue team (depending on the fire control situation) shall notify all external professional rescue agencies to carry out simple rescue work for the injured in a timely manner; the information release and liaison team shall notify the surrounding enterprises and villages.
In order to further improve the actual combat skills of employees in dealing with emergencies and promote enterprises to better carry out safe production work, Peak Health organized this emergency drill. This exercise has a clear division of labor and responsibility to people. In the first time when the danger occurs, it can ensure that the evacuation and rescue will not be flustered, and the logistics support will be in place. , , the rescue and relief will be timely and safe.
The drill also conducted emergency evacuation drills for office building staff at the fire scene, and organized all employees to operate fire extinguishers. (Wen / Zhou Guangliang Photo / Xu Feng)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31